116 related articles for article (PubMed ID: 19509553)
21. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancer.
Kim JG; Sohn SK; Chae YS; Cho YY; Bae HI; Yan G; Park JY; Lee MH; Chung HY; Yu W
Ann Oncol; 2007 Jun; 18(6):1030-6. PubMed ID: 17426061
[TBL] [Abstract][Full Text] [Related]
22. Association of vascular endothelial growth factor gene polymorphisms with susceptibility to epithelial ovarian cancer.
Li Y; Wang Y; Kang S; Wang N; Zhou RM; Duan YN; Sun DL; Qin JJ; Zhao W; Zhao L
Int J Gynecol Cancer; 2010 Jul; 20(5):717-23. PubMed ID: 20973260
[TBL] [Abstract][Full Text] [Related]
23. Explorative investigation of vascular endothelial growth factor receptor expression in primary ovarian cancer and its clinical relevance.
Wimberger P; Chebouti I; Kasimir-Bauer S; Lachmann R; Kuhlisch E; Kimmig R; Süleyman E; Kuhlmann JD
Gynecol Oncol; 2014 Jun; 133(3):467-72. PubMed ID: 24713547
[TBL] [Abstract][Full Text] [Related]
24. [Expression and clinical significance of endostatin and vascular endothelial growth factor in ovarian carcinoma].
Shi HR; Song WJ; Chen ZM; Wu QH
Ai Zheng; 2005 Sep; 24(9):1127-31. PubMed ID: 16159439
[TBL] [Abstract][Full Text] [Related]
25. Germline Polymorphisms of the VEGF Pathway Predict Recurrence in Nonadvanced Differentiated Thyroid Cancer.
Marotta V; Sciammarella C; Capasso M; Testori A; Pivonello C; Chiofalo MG; Gambardella C; Grasso M; Antonino A; Annunziata A; Macchia PE; Pivonello R; Santini L; Botti G; Losito S; Pezzullo L; Colao A; Faggiano A
J Clin Endocrinol Metab; 2017 Feb; 102(2):661-671. PubMed ID: 27849428
[TBL] [Abstract][Full Text] [Related]
26. Correlation of gene polymorphisms of vascular endothelial growth factor with grade and prognosis of lung cancer.
Liu C; Zhou X; Zhang Z; Guo Y
BMC Med Genet; 2020 Apr; 21(1):86. PubMed ID: 32354326
[TBL] [Abstract][Full Text] [Related]
27. Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival.
Chen CA; Cheng WF; Lee CN; Chen TM; Kung CC; Hsieh FJ; Hsieh CY
Gynecol Oncol; 1999 Aug; 74(2):235-40. PubMed ID: 10419737
[TBL] [Abstract][Full Text] [Related]
28. Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer.
Campos X; Muñoz Y; Selman A; Yazigi R; Moyano L; Weinstein-Oppenheimer C; Lara HE; Romero C
Gynecol Oncol; 2007 Jan; 104(1):168-75. PubMed ID: 16935322
[TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis.
Bradbury PA; Zhai R; Ma C; Xu W; Hopkins J; Kulke MJ; Asomaning K; Wang Z; Su L; Heist RS; Lynch TJ; Wain JC; Christiani D; Liu G
Clin Cancer Res; 2009 Jul; 15(14):4680-5. PubMed ID: 19584152
[TBL] [Abstract][Full Text] [Related]
30. Expression of cyclooxygenase-2 in epithelial ovarian tumors and its relation to vascular endothelial growth factor and p53 expression.
Lee JS; Choi YD; Lee JH; Nam JH; Choi C; Lee MC; Park CS; Juhng SW; Min KW
Int J Gynecol Cancer; 2006; 16 Suppl 1():247-53. PubMed ID: 16515599
[TBL] [Abstract][Full Text] [Related]
31. Investigation of Vascular Endothelial Growth Factor Polymorphisms on Risk, Metastasis, Laterality, and Prognosis of Colorectal Cancer in Turkish Subjects.
Cevik M; Namal E; Dinc-Sener N; Iner-Koksal U; Ciftci C; Susleyici B
Genet Test Mol Biomarkers; 2022 May; 26(5):298-306. PubMed ID: 35593899
[No Abstract] [Full Text] [Related]
32. VEGF polymorphisms and survival in early-stage non-small-cell lung cancer.
Heist RS; Zhai R; Liu G; Zhou W; Lin X; Su L; Asomaning K; Lynch TJ; Wain JC; Christiani DC
J Clin Oncol; 2008 Feb; 26(6):856-62. PubMed ID: 18281657
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors.
Färkkilä A; Anttonen M; Pociuviene J; Leminen A; Butzow R; Heikinheimo M; Unkila-Kallio L
Eur J Endocrinol; 2011 Jan; 164(1):115-22. PubMed ID: 21041381
[TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer.
Kim JG; Chae YS; Sohn SK; Cho YY; Moon JH; Park JY; Jeon SW; Lee IT; Choi GS; Jun SH
Clin Cancer Res; 2008 Jan; 14(1):62-6. PubMed ID: 18172253
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients.
Kassim SK; El-Salahy EM; Fayed ST; Helal SA; Helal T; Azzam Eel-D; Khalifa A
Clin Biochem; 2004 May; 37(5):363-9. PubMed ID: 15087251
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of intratumoral vascular endothelial growth factor as a marker of tumour angiogenesis in epithelial ovarian cancer.
Siddiqui GK; Elmasry K; Wong Te Fong AC; Perrett C; Morris R; Crow JC; Maclean AB
Eur J Gynaecol Oncol; 2010; 31(2):156-9. PubMed ID: 20527230
[TBL] [Abstract][Full Text] [Related]
38. Vascular endothelial growth factor (VEGF) gene polymorphisms may influence the efficacy of thalidomide in multiple myeloma.
Andersen NF; Vogel U; Klausen TW; Gimsing P; Gregersen H; Abildgaard N; Vangsted AJ
Int J Cancer; 2012 Sep; 131(5):E636-42. PubMed ID: 22139971
[TBL] [Abstract][Full Text] [Related]
39. Influence of the VEGF-A 936C>T germinal polymorphism on tumoral VEGF expression in head and neck cancer.
Formento JL; Etienne-Grimaldi MC; Francoual M; Pagès G; Onesto C; Formento P; Chamorey E; Dassonville O; Poissonnet G; Milano G
Pharmacogenomics; 2009 Aug; 10(8):1277-83. PubMed ID: 19663672
[TBL] [Abstract][Full Text] [Related]
40. RhoC expression level is correlated with the clinicopathological characteristics of ovarian cancer and the expression levels of ROCK-I, VEGF, and MMP9.
Zhao Y; Zong ZH; Xu HM
Gynecol Oncol; 2010 Mar; 116(3):563-71. PubMed ID: 20022093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
